1. Home
  2. DRMA vs WNW Comparison

DRMA vs WNW Comparison

Compare DRMA & WNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRMA
  • WNW
  • Stock Information
  • Founded
  • DRMA 2014
  • WNW 2015
  • Country
  • DRMA United States
  • WNW China
  • Employees
  • DRMA N/A
  • WNW N/A
  • Industry
  • DRMA Biotechnology: Pharmaceutical Preparations
  • WNW Catalog/Specialty Distribution
  • Sector
  • DRMA Health Care
  • WNW Consumer Discretionary
  • Exchange
  • DRMA Nasdaq
  • WNW Nasdaq
  • Market Cap
  • DRMA 4.5M
  • WNW 6.9M
  • IPO Year
  • DRMA 2021
  • WNW 2020
  • Fundamental
  • Price
  • DRMA $0.83
  • WNW $1.84
  • Analyst Decision
  • DRMA Strong Buy
  • WNW
  • Analyst Count
  • DRMA 1
  • WNW 0
  • Target Price
  • DRMA $6.00
  • WNW N/A
  • AVG Volume (30 Days)
  • DRMA 282.9K
  • WNW 6.7M
  • Earning Date
  • DRMA 05-19-2025
  • WNW 07-07-2025
  • Dividend Yield
  • DRMA N/A
  • WNW N/A
  • EPS Growth
  • DRMA N/A
  • WNW N/A
  • EPS
  • DRMA N/A
  • WNW N/A
  • Revenue
  • DRMA N/A
  • WNW $380,345.00
  • Revenue This Year
  • DRMA N/A
  • WNW N/A
  • Revenue Next Year
  • DRMA N/A
  • WNW N/A
  • P/E Ratio
  • DRMA N/A
  • WNW N/A
  • Revenue Growth
  • DRMA N/A
  • WNW N/A
  • 52 Week Low
  • DRMA $0.69
  • WNW $0.95
  • 52 Week High
  • DRMA $6.17
  • WNW $70.00
  • Technical
  • Relative Strength Index (RSI)
  • DRMA 43.16
  • WNW 45.93
  • Support Level
  • DRMA $0.73
  • WNW $1.84
  • Resistance Level
  • DRMA $0.99
  • WNW $2.27
  • Average True Range (ATR)
  • DRMA 0.08
  • WNW 0.36
  • MACD
  • DRMA 0.02
  • WNW 0.07
  • Stochastic Oscillator
  • DRMA 34.93
  • WNW 15.35

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc. is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to development and formulation of singular and combination products that can target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.

About WNW Meiwu Technology Company Limited

Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments: Clean Food Platform; Restaurant; and Others. The company generates the majority of its revenue from Technical services.

Share on Social Networks: